Distinct tumor-infiltrating lymphocyte landscapes are associated with clinical outcomes in localized non-small-cell lung cancer
Lorenzo Federico, Daniel J. McGrail, Salah-Eddine Bentebibel, Cara Haymaker, Angelo Ravelli, Marie‐Andrée Forget, Tatiana V. Karpinets, Peixin Jiang, Alexandre Reuben, Marcelo V. Negrão, J. Li, Roohussaba Khairullah, J. Zhang, A. Weissferdt, Ara A. Vaporciyan, Mara B. Antonoff, G. Walsh, S.-Y. Lin, P. Andrew Futreal, Ignacio I. Wistuba, Jack A. Roth, Lauren A. Byers, Pierre-Olivier Gaudreau, Naohiro Uraoka, A.F. Cruz, Hitoshi Dejima, Rossana Lazcano, Luisa M. Solis, Edwin R. Parra, J.J. Lee, Stephen G. Swisher, Tina Cascone, John V. Heymach, J. Zhang, Boris Sepesi, Don L. Gibbons, Chantale Bernatchez
Topics & Concepts
Tumor-infiltrating lymphocytesMedicineFlow cytometryCD8Cancer researchCD3PathologyLung cancerT cellImmune systemImmunologyCancer Immunotherapy and BiomarkersImmunotherapy and Immune ResponsesT-cell and B-cell Immunology